(Adnkronos) " Europe slows down, China accelerates: between 2013 and 2023, the European share of new clinical trials started in the world has fallen from 18% to 9%, while the Chinese share has risen from ...8% to 29% (Dati Efpia 2025). In order not to lag behind, Lombardy focuses on partnerships, digital transformation and competitiveness. [...]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
(Adnkronos) " Europe slows down, China accelerates: between 2013 and 2023, the European share of new clinical trials started in the world has fallen from 18% to 9%, while the Chinese share has risen from ...8% to 29% (Dati Efpia 2025). In order not to lag behind, Lombardy focuses on partnerships, digital transformation and competitiveness. [...]
(Adnkronos) " Europe slows down, China accelerates: between 2013 and 2023, the European share of new clinical trials started in the world has fallen from 18% to 9%, while the Chinese share has risen from ...8% to 29% (Dati Efpia 2025). In order not to lag behind, Lombardy focuses on partnerships, digital transformation and competitiveness. [...]